Target Price | $148.00 |
Price | $129.95 |
Potential |
13.89%
register free of charge
|
Number of Estimates | 6 |
6 Analysts have issued a price target Ingredion Incorporated 2026 .
The average Ingredion Incorporated target price is $148.00.
This is
13.89%
register free of charge
$168.00
29.28%
register free of charge
$125.00
3.81%
register free of charge
|
|
A rating was issued by 8 analysts: 4 Analysts recommend Ingredion Incorporated to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Ingredion Incorporated stock has an average upside potential 2026 of
13.89%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 7.43 | 7.49 |
8.95% | 0.82% | |
EBITDA Margin | 18.96% | 17.12% |
8.44% | 9.72% | |
Net Margin | 8.43% | 9.53% |
11.08% | 13.06% |
4 Analysts have issued a sales forecast Ingredion Incorporated 2025 . The average Ingredion Incorporated sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Ingredion Incorporated EBITDA forecast 2025. The average Ingredion Incorporated EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Ingredion Incorporated Analysts have issued a net profit forecast 2025. The average Ingredion Incorporated net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 9.71 | 11.07 |
1.15% | 14.01% | |
P/E | 11.74 | |
EV/Sales | 1.25 |
5 Analysts have issued a Ingredion Incorporated forecast for earnings per share. The average Ingredion Incorporated EPS is
This results in the following potential growth metrics and future valuations:
Ingredion Incorporated...
Analyst | Rating | Action | Date |
---|---|---|---|
UBS |
Locked
➜
Locked
|
Locked | Apr 07 2025 |
BMO Capital |
Locked
➜
Locked
|
Locked | Feb 05 2025 |
Oppenheimer |
Locked
➜
Locked
|
Locked | Feb 05 2025 |
Stephens & Co. |
Locked
➜
Locked
|
Locked | Feb 05 2025 |
UBS |
Locked
➜
Locked
|
Locked | Nov 15 2024 |
Barclays |
Locked
➜
Locked
|
Locked | Nov 06 2024 |
BMO Capital |
Locked
➜
Locked
|
Locked | Nov 06 2024 |
Analyst Rating | Date |
---|---|
Locked
UBS:
Locked
➜
Locked
|
Apr 07 2025 |
Locked
BMO Capital:
Locked
➜
Locked
|
Feb 05 2025 |
Locked
Oppenheimer:
Locked
➜
Locked
|
Feb 05 2025 |
Locked
Stephens & Co.:
Locked
➜
Locked
|
Feb 05 2025 |
Locked
UBS:
Locked
➜
Locked
|
Nov 15 2024 |
Locked
Barclays:
Locked
➜
Locked
|
Nov 06 2024 |
Locked
BMO Capital:
Locked
➜
Locked
|
Nov 06 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.